NCT06145178View on ClinicalTrials.gov

A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 22, 2023

Primary Completion Date

June 20, 2025

Study Completion Date

July 9, 2025

Conditions
Cytomegalovirus Infections
Interventions
BIOLOGICAL

SPYVAC01

Novel vaccine SPYVLP01

Trial Locations (2)

Unknown

Velocity Bristol, Bristol

Medicines Evaluation Unit, Manchester

All Listed Sponsors
lead

SpyBiotech Limited

INDUSTRY

NCT06145178 - A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants | Biotech Hunter | Biotech Hunter